Information about hormonal therapies for women with early breast cancer
This information has been developed to help you understand and make decisions about hormonal therapies for the treatment of breast cancer. The information has been developed by a multidisciplinary working group and is based on National Breast and Ovarian Cancer Centre Recommendations for Aromatase Inhibitors as Adjuvant Endocrine Therapy for Post-Menopausal Women with Hormone Receptor-Positive Early Breast Cancer. This document includes details of the research and references relating to this information. This information replaces Chapter 8 Hormonal Therapies in A Guide for Women with Early Breast Cancer (2003).
- What Are Hormonal Therapies?
- Menopause and oestrogen production
- How do hormonal therapies work?
- Why take hormonal therapies?
- When should I start taking hormonal therapies?
- Who should I talk to about hormonal therapies?
- Types of Hormonal Therapies
- Anti-oestrogens
- Aromatase inhibitors
- Anti-ovarian treatments
- Side Effects of Hormonal Therapies
- Additional side effects of anti-oestrogens
- Additional side effects of aromatase inhibitors
- Additional side effects of anti-ovarian treatments
- Deciding Whether To Use Hormonal Therapies
- After menopause: which hormonal therapy?
- What if I am already taking tamoxifen?
- Questions yet to be answered about aromatase inhibitors
- Questions to ask your doctor about hormonal therapies
